A merger involving Copley Acquisition Corp. and Ignite Proteomics has created a wholly owned subsidiary, with plans to list on the New York Stock Exchange.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A merger involving Copley Acquisition Corp. and Ignite Proteomics has created a wholly owned subsidiary, with plans to list on the New York Stock Exchange.